Member Info for Cloudy390

My take on this Dan, is that I’ve been here from the beginning and it seems like we are back to the beginning again but a lot further along the road with the products and still fully cashed up.
I will be excited to hear the results of the precision bio hook up , the results of MS trial, could be huge!!, Milciclib is still in the running with another trial ,which is what I invested in to start, So I am really happy with progress.
The buy back of $5 mill of shares on the open market is , to me, a master stoke! Genius.
These guys are not a scam they still have major products targeted in a $150 + Billion markets.
Alls well for me.

Fireside chat, lots of info, even I can understand the science better after all these years, not surprised they are excited.
Could not understand Yuan but hay ho Kunwar came up trumps.
If the SP stays low , no matter, Tlsa will buy $5mill cheap shares and sell them to finance next year
PMSL. Genius!!

You have licensed your product to a Car-t company to become an essential part of the formula.
Having signed a NDA and you know the Car-t is progressing better than expected. Armed with this info you could not personally buy shares but could the company buy shares !!! Shareholders would gain from that. Would that be legal???

Don’t forget that after the 30 consecutive days under a dollar and they get a warning from Nasdaq ,they have 180 days to rectify the situation. So no panic as excellent news will be soon , and if not we all just give up.

Precision Bio are partnered with Lily,
Just saying.

For positives!
https://investor.precisionbiosciences.com/static-files/8c16367d-5807-4263-b1f9-1e6478debc94
Page 8 & 26
Looks very promising. Available anti CD13 mabs are Rat,Mouse, and rabbit derived,and then there’s Foralumab.

Seem to forget the fda stalled progress and Brazil fda stalled progress and Covid actually stalled progress, thank god for SPMS trial and Car-t that we are still in the game. Cheap as chips you lucky people

If your opinion or your reaction is favourable to something, you agree with it and approve of it.

That’s why the FDA approved another patient, 3months time if still favourable the FDA may consider approval of a larger trial. We wait. Meanwhile I would guess they are getting favourable interest at the conference.

Maybe,it’s possible etc over a month or so!!! The spike happened over one day.
Morefool them if they are stupid, but I don’t see it .

Can the trades be seen to be ‘robin hood’ or is that just speculation ?

Ridiculous ! $150 Sp for $10 PMSL.
It was as GC said Aim dragged the price down .

Nice one!
Confusing Tlsa with Tsla , don’t believe it, share price difference for a start, yanks ain’t stupid.
It’s as GC said ,pipeline etc , bit of covid panic.

I for one think he knows exactly what he is doing. Very flexible acumen in an ever changing map.

Thanks!
Bit of bedtime youtube ??
Happy New year All!!!

Yes got mine on AJ Bell.

Obviously not.
But all eyes in pharma world will be focussed on finding an immuno suppressive anti imflamitory drug that is easy to administer, funny that is what Tils has said all along for years. Do you know of such a drug because I’m sure it will be in demand, especially if it works in other immuno suppressive indications and is very well tolerated.

Dunk
https://pubmed.ncbi.nlm.nih.gov/34475873/

Foralumab is said to be able to relieve the hyper inflammatory stage of covid causing all the damage, which all the others are not. Bingo!!

I read a week of two ago that 2022 is a bumper cash rich year for BMS and will be looking for M&A’s.
As we bought the licence off BSM who had it from Nonimmune the owners , because BSM did not know what to do with let Tils have.
Just saying that maybe ,just maybe, interest might be forthcoming. GLA

So all the mab competition with foralumab has now disappeared.
Foralumab is the only fully human mab that is anti CD3 and administered nasally.
They said that infusion administration was not very good and efficacy poor AND that the way forward is regulating the immune system to regulate immune response. Anybody know a mab that does that??
Big News IMHO